lobbying_activities: 2777343

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2777343	743981bc-a9be-4270-8b88-799ec2d4a3a3	Q1	ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)	400762305	PHRMA (PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA)	2022	first_quarter	PHA	Issues relating to drug pricing, value and transparency, generally. Issues relating to medical research and development, as well as access to medicines	HOUSE OF REPRESENTATIVES,SENATE			0	0	2022-04-17T16:20:58-04:00